Intraoperative radiation therapy for high-risk pediatric neuroblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 4, 2000, Pages 985-992

  Haas Kogan, Daphne A ^a   Fisch, Benjamin M ^a   Wara, William M ^a   Swift, Patrick S ^a   Farmer, Diana L ^a   Harrison, Michael R ^a   Albanese, Craig ^a   Weinberg, Vivian ^a   Matthay, Katherine K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Alta Bates Medical Center   (United States)

Author keywords

Intraoperative radiation; Neuroblastoma; Pediatric

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; MALE; NEUROBLASTOMA; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTRAOPERATIVE PERIOD; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RETROPERITONEAL NEOPLASMS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0034237688     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00432-6     Document Type: Article

References (59)

1. Cheung N.V., Heller G. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol. 9:1991;1050-1058.
2. Kiely E.M. The surgical challenge of neuroblastoma. J Pediatr Surg. 29:1994;128-133.
3. Matthay K.K., Seeger R.C., Reynolds C.P., et al. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma A report from the Childrens Cancer Group . J Clin Oncol. 12:1994;2382-2389.
4. Matthay K.K., O'Leary M.C., Ramsay N.K., et al. Role of myeloablative therapy in improved outcome for high risk neuroblastoma Review of recent Children's Cancer Group results . Eur J Cancer. 31A:1995;572-575.
5. Pole J.G., Casper J., Elfenbein G., et al. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma A Pediatric Oncology Group study . J Clin Oncol. 9:1991;152-158.
6. Ladenstein R., Lasset C., Hartmann O., et al. Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis A report from the European Group for Bone Marrow Transplantation . J Clin Oncol. 11:1993;2330-2341.
7. Kushner B.H., O'Reilly R.J., Mandell L.R., Gulati S.C., et al. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol. 9:1991;274-279.
8. Matthay K.K., Atkinson J.B., Stram D.O., et al. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma A Childrens Cancer Group pilot study . J Clin Oncol. 11:1993;2226-2233.
9. Ohnuma N., Takahashi H., Kaneko M., et al. Treatment combined with bone marrow transplantation for advanced neuroblastoma an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan . Med Pediatr Oncol. 24:1995;181-187.
10. Philip T., Zucker J.M., Bernard J.L., et al. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis Is cure possible in a small subgroup? J Clin Oncol. 9:1991;1037-1044.
11. Matthay K.K., Sather H.N., Seeger R.C., et al. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol. 7:1989;236-244.
12. Evans A.E., Silber J.H., Shpilsky A., et al. Successful management of low-stage neuroblastoma without adjuvant therapies A comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution . J Clin Oncol. 14:1996;2504-2510.
13. Castleberry R.P., Kun L.E., Shuster J.J., et al. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol. 9:1991;789-795.
14. August C.S., Serota F.T., Koch P.A., et al. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol. 2:1984;609-616.
15. Rosen E.M., Cassady J.R., Frantz C.N., et al. Neuroblastoma The Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience . J Clin Oncol. 2:1984;719-732.
16. Shafford E.A., Rogers D.W., Pritchard J. Advanced neuroblastoma Improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26 . J Clin Oncol. 2:1984;742-747.
17. Matthay K.K. Neuroblastoma Biology and therapy . Oncology. 11:1997;1857-1866.
18. Hawkins M.M. Second primary tumors following radiotherapy for childhood cancer. Int J Radiat Oncol Biol Phys. 19:1990;1297-1301.
19. Meadows A.T. Second malignant neoplasms in childhood cancer survivors. J Assoc Pediatr Oncol Nurses. 6:1989;7-11.
20. Donaldson S.S. Lessons from our children. Int J Radiat Oncol Biol Phys. 26:1993;739-749.
21. Abe M., Takahashi M. Intraoperative radiotherapy The Japanese experience . Int J Radiat Oncol Biol Phys. 7:1981;863-868.
22. Abe M., Shibamoto Y. The usefulness of intraoperative radiation therapy in the treatment of pelvic recurrence of cervical cancer. Int J Radiat Oncol Biol Phys. 34:1996;513-514.
23. Hanks G.E., Lanciano R.M. Intraoperative radiation therapy Cut bait or keep on fishing? Int J Radiat Oncol Biol Phys. 34:1996;515-517.
24. Kim H.K., Jessup J.M., Beard C.J., et al. Locally advanced rectal carcinoma Pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy . Int J Radiat Oncol Biol Phys. 38:1997;777-783.
25. Matsumoto K., Kakizoe T., Mikuriya S., et al. Clinical evaluation of intraoperative radiotherapy for carcinoma of the urinary bladder. Cancer. 47:1981;509-513.
26. Haase G.M., Meagher D.P. Jr, McNeely L.K., et al. Electron beam intraoperative radiation therapy for pediatric neoplasms. Cancer. 74:1994;740-747.
27. Aitken D.R., Hopkins G.A., Archambeau J.O., et al. Intraoperative radiotherapy in the treatment of neuroblastoma Report of a pilot study . Ann Surg Oncol. 2:1997;343-350.
28. Leavey P.J., Odom L.F., Poole M., et al. Intra-operative radiation therapy in pediatric neuroblastoma. Med Pediatr Oncol. 28:1997;424-428.
29. Merchant T.E., Zelefsky M.J., Sheldon J.M., et al. High-dose rate intraoperative radiation therapy for pediatric solid tumors. Med Pediatr Oncol. 30:1998;34-39.
30. Nag S., Retter E., Martinez-Monge R., et al. Feasibility of intraoperative electron beam radiation therapy in the treatment of locally advanced pediatric malignancies. Med Pediatr Oncol. 32:1999;382-384.
31. Brodeur G.M., Seeger R.C., Barrett A., et al. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. Prog Clin Biol Res. 271:1988;509-524.
32. Brodeur G.M., Pritchard J., Berthold F., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 11:1993;1466-1477.
33. Seeger R.C., Brodeur G.M., Sather H., et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 313:1985;1111-1116.
34. Shimada H, Chatten J, Newton WA Jr; et al. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Nat Cancer Inst 1984;73:405-416.
35. Hann H.W., Evans A.E., Siegel S.E., et al. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma The Childrens Cancer Study Group experience . Cancer Res. 45:1985;2843-2848.
36. Chatten J., Shimada H., Sather H.N., et al. Prognostic value of histopathology in advanced neuroblastoma A report from the Childrens Cancer Study Group . Hum Pathol. 19:1998;1187-1198.
37. Crabbe D.C., Peters J., Seeger R.C. Rapid detection of MYCN gene amplification neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol. 1:1992;229-234.
38. Meurk M.L., Goer D.A., Spalek G., et al. The Mobetron A new concept for IORT . Front Radiat Ther Oncol. 31:1997;65-70.
39. Matthay K.K., Perez C., Seeger R.C., et al. Successful treatment of stage III neuroblastoma based on prospective biologic staging A Children's Cancer Group study . J Clin Oncol. 16:1998;1256-1264.
40. Bowman L.C., Castleberry R.P., Cantor A., et al. Genetic staging of unresectable or metastatic neuroblastoma in infants A Pediatric Oncology Group study . J Natl Cancer Inst. 89:1997;373-380.
41. Powis M.R., Imeson J.D., Holmes S.J. The effect of complete excision on stage III neuroblastoma A report of the European Neuroblastoma Study Group . J Pediatr Surg. 31:1996;516-519.
42. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow tranplantation, and 13-cis-retinoic acid. N Engl J Med. 341:1999;1165-1173.
43. Stram D.O., Matthay K.K., O'Leary M., et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma A report of two concurrent Children's Cancer Group studies . J Clin Oncol. 14:1996;2417-2426.
44. Ikeda H., August C.S., Goldwein J.W., et al. Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory "debulking" treatments. J Pediatr Surg. 27:1992;1438-1441.
45. Sitarz A., Finkelstein J., Grosfield J., et al. An evaluation of the role of surgery in disseminated neuroblastoma A report from the Children's Cancer Study Group . J Pediatr Surg. 18:1983;147-151.
46. Haase G.M., Wong K.Y., deLorimer A.A., et al. Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg. 24:1989;194-200.
47. Haase G.M., O'Leary M.C., Ramsay N.K., et al. Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg. 26:1991;1119-1123.
48. Le Tourneau J.N., Bernard J.L., Hendren W.H., et al. Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg. 20:1985;244-249.
49. Tsuchida Y., Yokoyama J., Kaneko M., et al. Therapeutic significance of surgery in advanced neuroblastoma A report from the study group of Japan . J Pediatr Surg. 27:1992;616-622.
50. O'Neill J.A., Littman P., Blitzer P., et al. The role of surgery in localized neuroblastoma. J Pediatr Surg. 20:1985;708-712.
51. Evans A.E., D'Angio G.J., Sather H.N., et al. A comparison of four staging systems for localized and regional neuroblastoma A report from the Childrens Cancer Study Group . J Clin Oncol. 8:1990;678-688.
52. La Quaglia M.P., Kushner B.H., Heller G., et al. Stage 4 neuroblastoma diagnosed at more than 1 year of age Gross total resection and clinical outcome . J Pediatr Surg. 29:1994;1162-1165.
53. Cecchetto G., Luzzatto C., Carli M., et al. The role of surgery in non-localized neuroblastoma. Analysis of 59 cases. Tumori. 69:1983;327-329.
54. DeCou J.M., Bowman L.C., Rao B.N., et al. Infants with metastatic neuroblastoma have improved survival with resection of the primary tumor. J Pediatr Surg. 30:1995;937-940.
55. Shorter N.A., Davidoff A.M., Evans A.E., et al. The role of surgery in the management of stage IV neuroblastoma A single institution study . Med Pediatr Oncol. 24:1995;287-291.
56. Matsumura M., Atkinson J.B., Hays D.M., et al. An evaluation of the role of surgery in metastatic neuroblastoma. J Pediatr Surg. 23:1988;448-453.
57. Kremens B., Klingebiel T., Hermann F., et al. High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma. Med Pediatr Oncol. 23:1994;470-475.
58. Donnelly L.F., Rencken I.O., Shardell K., et al. Renal cell carcinoma after therapy for neuroblastoma. AJR Am J Roentgenol. 167:1996;915-917.
59. Halperin E.C. Long-term results of therapy for stage C neuroblastoma. J Surg Oncol. 63:1996;172-178.